Werewolf Therapeutics Inc

HOWLNASDAQ · USD
0.92USD0.00 (+1.36%)
4310

Werewolf Therapeutics Inc (HOWL) Unusual Options Activity Today

HOWL options volume power reached 1.01x on the previous trading day. The highest reading was on the $0.5 CALL expiring 2026-10-16.

Read more

Checking HOWL unusual options activity helps you spot when traders are making outsized bets on Werewolf Therapeutics Inc before the broader market catches on. Werewolf Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor HOWL unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching HOWL unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking HOWL unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and HOWL unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma.

The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Catalysts rarely arrive without a footprint, and HOWL unusual options activity is often where that footprint shows up first. Our scanner tracks Werewolf Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at HOWL unusual options volume on the call side or chasing put sweeps, Werewolf Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
0.500.450.550.50373%147146100.68%
1.00—0.100.10156%01300.00%
1.50—0.100.10294%00—
2.00—0.400.40751%00—
2.50—0.050.05345%03,5000.00%
Puts
0.50—0.250.25803%00—
1.00—0.450.45517%010.00%
1.500.300.850.58135%00—
2.000.801.351.08196%00—
2.501.301.851.58242%0210.00%

As of September 30, 2026

Spot unusual options activity before it moves

Track HOWL options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial